Flexibility as a Strategy in Nucleoside Antiviral Drug Design

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|22|34|3910-3921

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.34, 2015-11, pp. : 3910-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developments in Antiviral Drug Design, Discovery and Development in 2004

By  

Current Drug Targets - Infectious Disorders, Vol. 5, Iss. 4, 2005-12 ,pp. : 307-400

Bentham Science Publishers

Access to resources Recommend Favorite

Tackling the challenges posed by target flexibility in drug design

By Beier Christian   Zacharias Martin  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 4, 2010-04 ,pp. : 347-359

Informa Healthcare

Access to resources Recommend Favorite

Accommodating Protein Flexibility for Structure-Based Drug Design

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 2, 2011-01 ,pp. : 171-178

Bentham Science Publishers

Access to resources Recommend Favorite

Strategy of Computer-Aided Drug Design

By  

Current Drug Targets - Infectious Disorders, Vol. 3, Iss. 1, 2003-03 ,pp. : 33-40

Bentham Science Publishers

Access to resources Recommend Favorite

Antiviral Nucleoside Analogs Phosphorylation by Nucleoside Diphosphate Kinase

By  

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 4, 2004-05 ,pp. : 361-369

Bentham Science Publishers

Access to resources Recommend Favorite